Peptide Drugs advanced
GLP-1 and Parkinsons
Clinical trials evaluating neuroprotection including exenatide and lixisenatide studies.
By Encyclopeptide Editorial | 1 min read
glp1 neuroprotection parkinsons
GLP-1 and Parkinsons
Overview
Clinical trials evaluating neuroprotection including exenatide and lixisenatide studies.
Structure
| Property | Value |
|---|---|
| Name | GLP-1 and Parkinsons |
Mechanism of Action
GLP-1 receptor activation reduces neuroinflammation and improves mitochondrial function.
References
- Wikipept Peptide Database
- Primary literature (see individual entries)
Chemical Identity
| Property | Value |
|---|---|
| Name | GLP-1 and Parkinsons |
| Category | Peptide Drugs |
Test Your Knowledge
Reinforce what you learned about GLP-1 and Parkinsons with interactive quizzes on Wikipept.
Take a Quiz on Wikipept